ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
711P Nivolumab + ipilimumab (N+I) vs sunitinib (S) for first-line treatment of advanced renal cell carcinoma (aRCC) in CheckMate 214: 4-year follow-up and subgroup analysis of patients (pts) without nephrectomy
Annals of Oncology
◽
10.1016/j.annonc.2020.08.783
◽
2020
◽
Vol 31
◽
pp. S559-S560
◽
Cited By ~ 2
Author(s):
L. Albiges
◽
N. Tannir
◽
M. Burotto
◽
D.F. McDermott
◽
E.R. Plimack
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Subgroup Analysis
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
Related Documents
Cited By
References
Randomized phase III trial of avelumab + axitinib vs sunitinib as first-line treatment for advanced renal cell carcinoma: JAVELIN renal 101 Japanese subgroup analysis
Annals of Oncology
◽
10.1093/annonc/mdz249.052
◽
2019
◽
Vol 30
◽
pp. v386-v387
Author(s):
M. Uemura
◽
Y. Tomita
◽
H. Miyake
◽
S. Hatakeyama
◽
H.-O. Kanayama
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Subgroup Analysis
◽
Renal Cell
◽
Phase Iii
◽
Advanced Renal Cell Carcinoma
◽
Line Treatment
◽
First Line
◽
Phase Iii Trial
◽
First Line Treatment
Download Full-text
First-line treatment in the management of advanced renal cell carcinoma: systematic review and network meta-analysis
Expert Opinion on Pharmacotherapy
◽
10.1517/14656566.2015.1058359
◽
2015
◽
Vol 16
(13)
◽
pp. 1915-1927
◽
Cited By ~ 15
Author(s):
James Larkin
◽
Abby Paine
◽
Grace Foley
◽
Stephen Mitchell
◽
Connie Chen
Keyword(s):
Systematic Review
◽
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Meta Analysis
◽
Advanced Renal Cell Carcinoma
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
Cost-effectiveness of pembrolizumab with axitinib as first-line treatment for advanced renal cell carcinoma
Current Medical Research and Opinion
◽
10.1080/03007995.2020.1799771
◽
2020
◽
Vol 36
(9)
◽
pp. 1507-1517
Author(s):
Arielle G. Bensimon
◽
Yichen Zhong
◽
Umang Swami
◽
Allison Briggs
◽
Joshua Young
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cost Effectiveness
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
The Lancet Oncology
◽
10.1016/s1470-2045(19)30413-9
◽
2019
◽
Vol 20
(10)
◽
pp. 1370-1385
◽
Cited By ~ 157
Author(s):
Robert J Motzer
◽
Brian I Rini
◽
David F McDermott
◽
Osvaldo Arén Frontera
◽
Hans J Hammers
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Line Treatment
◽
Efficacy And Safety
◽
First Line
◽
Phase 3
◽
Randomised Controlled
◽
First Line Treatment
Download Full-text
Correction to: “Correction to: Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its use”
Drugs & Therapy Perspectives
◽
10.1007/s40267-019-00613-z
◽
2019
◽
Vol 35
(4)
◽
pp. 200-200
Author(s):
Katherine A. Lyseng-Williamson
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its use
Drugs & Therapy Perspectives
◽
10.1007/s40267-018-0547-6
◽
2018
◽
Vol 34
(10)
◽
pp. 457-465
◽
Cited By ~ 4
Author(s):
Katherine A. Lyseng-Williamson
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
Phase 3 study of avelumab in combination with axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma (aRCC)
Annals of Oncology
◽
10.1093/annonc/mdw373.71
◽
2016
◽
Vol 27
◽
pp. vi293
◽
Cited By ~ 2
Author(s):
R.J. Motzer
◽
T. Choueiri
◽
J. Larkin
◽
L. Albiges
◽
J.B. Haanen
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Line Treatment
◽
First Line
◽
Phase 3
◽
First Line Treatment
Download Full-text
Costs Associated with Health Care Resource Use in Patients with Advanced Renal Cell Carcinoma Receiving First-Line Treatment with Pazopanib Versus Sunitinib
Value in Health
◽
10.1016/j.jval.2014.03.452
◽
2014
◽
Vol 17
(3)
◽
pp. A77-A78
Author(s):
M.D. Hackshaw
◽
R.N. Hansen
◽
S.P. Nagar
◽
B. Arondekar
◽
K.C. Deen
◽
...
Keyword(s):
Health Care
◽
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Resource Use
◽
Renal Cell
◽
Health Care Resource
◽
Advanced Renal Cell Carcinoma
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
PCN10 Targeted Therapy (TT) for First Line Treatment of Advanced Renal Cell Carcinoma (RCC): An Indirect Comparison Meta-Analysis (ICMA)
Value in Health
◽
10.1016/j.jval.2012.03.1128
◽
2012
◽
Vol 15
(4)
◽
pp. A209
Author(s):
W. Matheus
◽
M.A. Duran
◽
O.A.C. Clark
◽
A. Kumar
◽
U. Ferreira
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Targeted Therapy
◽
Cell Carcinoma
◽
Renal Cell
◽
Meta Analysis
◽
Indirect Comparison
◽
Advanced Renal Cell Carcinoma
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
LBA29 Nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced renal cell carcinoma: A randomized phase II trial (PRISM)
Annals of Oncology
◽
10.1016/j.annonc.2021.08.2105
◽
2021
◽
Vol 32
◽
pp. S1304-S1305
Author(s):
N.S. Vasudev
◽
G. Ainsworth
◽
S. Brown
◽
L. Pickering
◽
T.S. Waddell
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Renal Cell
◽
Phase Ii Trial
◽
Advanced Renal Cell Carcinoma
◽
Line Treatment
◽
First Line
◽
Randomized Phase Ii
◽
First Line Treatment
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close